Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.19 USD | +0.63% | -1.85% | -23.04% |
Evolution of the average Target Price on Leap Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Leap Therapeutics, Inc.
Baird | |
Mizuho Securities | |
Raymond James | |
HC Wainwright | |
Piper Sandler |
EPS Revisions
- Stock Market
- Equities
- LPTX Stock
- Consensus Leap Therapeutics, Inc.